Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation
In patients with AF not receiving oral anticoagulation, NFL was the only neuroglial biomarker significantly and independently associated with the risk of ischemic stroke and death. Further studies evaluating NFL for stroke risk assessment in patients with AF and the impact of contemporary oral anticoagulation treatment are warranted.
Authors
- Karl Sjölin (ORCID: https://orcid.org/0000-0002-6693-1348)
- Johan Lindbäck (ORCID: https://orcid.org/0000-0002-6473-8798)
- Julia Aulin (ORCID: https://orcid.org/0000-0002-9193-5068)
- Lars Wallentin (ORCID: https://orcid.org/0000-0003-0378-6531)
- Alexander P. Benz (ORCID: https://orcid.org/0000-0003-2555-1266)
- Kim Kultima (ORCID: https://orcid.org/0000-0002-0680-1410)
- Joachim Burman (ORCID: https://orcid.org/0000-0002-7045-1806)
- Jonas Oldgren (ORCID: https://orcid.org/0000-0002-9969-3921)
- John W. Eikelboom (ORCID: https://orcid.org/0000-0003-4126-1285)
Institutions
- Uppsala University (SE)
- Johannes Gutenberg University Mainz (DE)
- Population Health Research Institute (CA)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- McMaster University (CA)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1161/jaha.124.038860
- Citations
- 3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.21